ArticleJournal of gastrointestinal oncology2024
Liposomal eribulin (E7389-LF) plus nivolumab: a potential treatment option for patients with advanced gastric cancer?
Ali Raza Shaikh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.